Odyssey Health (ODYY) Receivables - Net (2016 - 2024)

Odyssey Health (ODYY) reported Receivables - Net of $22625.0 for Q3 2024, up 2050.67% sequentially from $1052.0 in Q4 2017.

Odyssey Health (ODYY) Receivables - Net (2016 - 2024) Analysis & Trends

Odyssey Health has disclosed Receivables - Net across 3 years of filings, most recently posting $22625.0 for Q3 2024.

Quarterly Receivables - Net changed N/A year-over-year to $22625.0 in Q3 2024, while the trailing twelve-month figure through Jul 2024 was $22625.0 (changed N/A YoY) and the FY2024 annual result came in at $22625.0, changed N/A from the prior year.
Receivables - Net climbed to $22625.0 in Q3 2024, from $1052.0 in the prior quarter.
Across five years, Receivables - Net topped out at $22625.0 in Q3 2024 and bottomed at $22625.0 in Q3 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn
10	Odyssey Health	-	-	-

Download Data